Indeed, CDKN2A is deleted in 22% of osteosarcomas and CDK4 is amplified in 28% of oral melanomas, resulting in frequent cell cycle gene alteration in both tumor types (Supplementary Data 3). The gene discussed is CDKN2A; the disease is neoplasm.